News

Enerpac Tool Group: Insights on Upcoming Earnings Report

Enerpac Tool Group: Insights on Upcoming Earnings Report

Enerpac Tool Group's Upcoming Earnings Report

Enerpac Tool Group (NYSE:EPAC) is scheduled to release its latest quarterly earnings report soon. Investors are keenly awaiting details about the company's financial performance and potential opportunities for growth. Understanding earnings projections can be crucial for making informed decisions in the market.

Expected Earnings Performance

Analysts anticipate Enerpac Tool Group will report an earnings per share (EPS) of $0.51. This figure indicates the market's expectations for the company's financial results and serves as a benchmark for performance evaluation post-release.

Recent Trends and Market Sentiment

With the anticipation of the earnings announcement, investors are focused on whether Enerpac Tool Group can exceed these estimates. The confidence is several news sources suggesting the company is likely to provide positive guidance for the upcoming quarter, which could reflect a favorable outlook amid challenging market conditions.

Review of Past Earnings Results

In the previous quarter, Enerpac Tool Group exceeded expectations, reporting an EPS that surpassed estimates by $0.04. However, despite the beat, the stock experienced a decline of 5.91% in the following trading day, illustrating how market reactions are not solely based on performance outcomes.

Earnings History Overview

Taking a closer look at Enerpac Tool Group's recent earnings results reveals fluctuations in stock performance over the quarters:

  • Q3 2025: EPS Estimate: 0.47, Actual: 0.51, Price Change: -6.00%
  • Q2 2025: EPS Estimate: 0.40, Actual: 0.39, Price Change: 8.00%
  • Q1 2025: EPS Estimate: 0.41, Actual: 0.40, Price Change: -2.00%
  • Q4 2024: EPS Estimate: 0.53, Actual: 0.50, Price Change: -1.00%

Current Share Price and Performance Analysis

As of the latest market close, Enerpac Tool Group shares were trading at $39.53. The stock has shown a decline of 7.83% over the past year, which may contribute to bearish sentiment among long-term shareholders as they prepare for the upcoming earnings announcement.

Industry Analyst Perspectives

Understanding the opinions of analysts can provide valuable insight into the market's perspective on Enerpac Tool Group. Currently, the company has received a consensus rating of Buy, with an average price target of $48.00, which implies a 21.43% upside potential for investors.

Industry Comparisons and Market Positioning

Analysts consistently analyze Enerpac Tool Group alongside its peers, comparing performance metrics that can influence investment decisions. Understanding how the company stacks up against industry counterparts can shed light on its potential trajectory:

  • Hillman Solutions: Buy, with a target of $12.33.
  • Albany International: Neutral, with a target of $67.00.
  • Helios Technologies: Outperform, with a target of $49.67.

Peer Performance Overview

An analysis of financial metrics shows Enerpac Tool Group leading in revenue growth and gross profit relative to competitors. While its return on equity may lag, the overall financial positioning remains positive:

  • Enerpac Tool Group: Buy, 5.50% revenue growth, $79.90M gross profit.
  • Hillman Solutions: Buy, 6.16% revenue growth.
  • Albany International: Neutral, -6.20% revenue growth.
  • Helios Technologies: Outperform, -3.37% revenue growth.

About Enerpac Tool Group

Enerpac Tool Group Corp specializes in providing high-precision tools and controlled-force products for heavy lifting applications. The company's operations extend across various sectors, including industrial maintenance and power generation, making them essential players in the hydraulic and mechanical tool industry.

Financial Insights and Health Assessment

Examining Enerpac's financial health reveals several key indicators:

  • Market Capitalization: The company’s market cap reflects a scale below the industry average, potentially indicating growth opportunities.
  • Revenue Growth: Achieved a revenue growth rate of approximately 5.5%, showing a positive upward trend compared to peers.
  • Net Margin: A robust net margin of 13.89% showcases effective cost management.
  • Return on Equity (ROE): A commendable 5.22% indicates satisfactory utilization of equity.
  • Debt Management: A debt-to-equity ratio of 0.44 suggests a balanced and prudent financial strategy.

Frequently Asked Questions

What is the expected EPS for Enerpac Tool Group?

Analysts expect an earnings per share (EPS) of $0.51 for the upcoming earnings report.

How has Enerpac performed in recent quarters?

Recently, the company reported an EPS beat by $0.04, but the stock price dipped following the announcement.

What is the current rating for Enerpac Tool Group?

The consensus rating for Enerpac Tool Group is currently a Buy, indicating positive analyst sentiment.

What are Enerpac's advantages over its peers?

Enerpac leads with strong revenue growth and gross profit metrics compared to other companies in the industry.

What is Enerpac Tool Group's market capitalization?

The company’s market capitalization is below industry averages, indicating potential growth opportunities ahead.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sky Labs' CART Monitor Advances BP Monitoring Tech

Updated Category News Views 3

Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...

Continue Reading
EQT Wraps Up Share Buyback with 4.3M Shares Repurchased

Updated Category News Views 1

EQT's Bold Buyback: Crunching the Numbers Alright, let's peel back the curtain on EQT's latest maneuver—finishing up their share buyback program, all neat and tidy for 2026. They nailed down 707,203 of their own shares just in the first week of September, part of a grand total of 4,368,899 snatched up in the entire effort. That's a whopping SEK 1.448 billion invested in...

Continue Reading
Hyosung Targets U.S. AI Power Market with Advanced SST

Updated Category News Views 1

Hyosung's Game-Changing Move in the AI Power Sector Guess what? The AI era's heating up, and it's dragging the power sector along for a wild ride. Hyosung Chairman Hyun-Joon Cho peered into that future and decided it's all-in time for the U.S. power market. With AI and data centers cranking up power demands like never before, those rickety old wires need an upgrade fast....

Continue Reading
Stem Cell Market Set for Major Gains to 2031

Updated Category News Views 1

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 5

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Consumer365 Highlights Happy Head's Personalized Hair Solutions

Updated Category News Views 1

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Continue Reading
Beazer Homes Sale Scrutinized for Shareholder Impact

Updated Category News Views 1

Spotlight on Beazer Homes' Proposed Sale Here's a real head-scratcher for folks in the stock trenches: Beazer Homes USA, Inc. (NYSE: BZH) finds itself under the microscope with Halper Sadeh LLC stirring the pot. You can't make this up—just another day in the world of investor rights and looming litigation. Questions Arise Over Shareholder Gains Halper Sadeh LLC, that...

Continue Reading
Lida Group Expands Global Modular Construction Services

Updated Category News Views 5

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Continue Reading
CABP Market Sees Potential in New Treatments Rising

Updated Category News Views 2

Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...

Continue Reading
UST Grabs Italdesign: Driving Future Mobility with AI

Updated Category News Views 3

UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...

Continue Reading

Top 5 Most Recently Viewed Articles

Precision BioSciences Expands Leadership Team for Growth

Updated Category News Views 134

Precision BioSciences Expands Leadership Team for Growth Precision BioSciences, Inc. (Nasdaq: DTIL), a pioneering clinical-stage gene editing company, has made significant changes to its senior leadership team as it aims to advance its in vivo gene editing programs, including the promising PBGENE-HBV project currently in Phase 1 clinical studies. Strategic Leadership...

Continue Reading
Understanding Qualcomm's Short Interest Trends and Implications

Updated Category News Views 201

Qualcomm Short Interest Overview Qualcomm (QCOM) has recently reported a significant decrease in its short percent of float, which has dropped by 9.4% since the last report. Currently, there are 21.02 million shares sold short, representing 2.12% of the company's total regular shares available for trading. Based on recent trading volumes, it would take approximately 2.25...

Continue Reading
Simply Good Foods Company Delivers Strong Q1 Performance

Updated Category News Views 117

Simply Good Foods Company Shows Positive Growth Simply Good Foods Company (NASDAQ: SMPL), a leader in the nutrition snack industry, has reported impressive financial results for its fiscal first quarter, ending November 30, 2024. This period marks a significant year-over-year improvement in sales and profitability. Financial Highlights of Q1 2025 Impressive Sales and...

Continue Reading
Denmark's Bold Move to Safeguard Personal Identity Rights Against AI

Updated Category News Views 272

Denmark's Progressive Stance on Deepfake Technology Denmark is taking a significant step in the realm of digital privacy by updating its copyright laws to safeguard individual rights against deepfake technology. This innovative move allows citizens to have legal ownership of their own faces, voices, and bodies. In a world where AI-generated imitations are becoming...

Continue Reading
Spotlight Biographees: Celebrating Remarkable Achievements

Updated Category News Views 284

Spotlight Biographees: Celebrating Remarkable Achievements The Spotlight Series highlights the impressive resumes and career accomplishments of hand-selected professionals. Marquis Who's Who (MWW), the leading biographical publisher globally, proudly acknowledges a diverse group of professionals recognized in the Spotlight Series for their outstanding contributions. This...

Continue Reading